Browse studies

Find your next paid study

8 recruiting studies matching your filters

AGENT DCB STANCE: AGENT Drug-Coated Balloon for STent AvoidANCE in PCI for De Novo Coronary Artery Disease

AGENT DCB STANCE is a prospective, multicenter, open-label, 1:1 randomized controlled study designed to assess the safety and effectiveness of a treatment stra…

Coronary Arterial Disease (CAD)de Novo Lesions in Native Coronary Arteries

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Boston Scientific CorporationNCT06959524

Phase 4

Comparison of ABCD-GENE Score-Guided Versus Unguided DAPT De-Escalation: A Prospective Randomized Pharmacodynamic Study in Patients Undergoing PCI The Switching Antiplatelet-9 (SWAP-9) Study

The purpose of this study is to compare the pharmacodynamic effects of ABCD-GENE guided vs. unguided de-escalation strategies among patients on dual antiplatel…

Coronary Arterial Disease (CAD)

Estimated

~$25 – $1,000

Actual pay is set by the research site.

University of FloridaNCT06588595

Observational

Group Singing or Solo Singing to Improve Vascular Health in Older Adults With Coronary Artery Disease: A Feasibility Study

Unlike traditional physical exercise, the impact of singing on cardiovascular health has not been extensively studied. Endothelial dysfunction predicts cardiov…

ElderlyCoronary Arterial Disease (CAD)

Estimated

~$10 – $750

Actual pay is set by the research site.

Medical College of WisconsinNCT07881692

Phase 4

Switching From Clopidogrel to Low-dose Prasugrel in Patients at Dual-risk Following Percutaneous Coronary Intervention (TAILOR-BLEED-2)

The primary aim of this study is to investigate the PD effects of switching from standard-dose clopidogrel dose to low-dose prasugrel versus continuing standar…

Coronary Arterial Disease (CAD)Percutaneous Coronary Intervention (PCI)

Estimated

~$25 – $1,000

Actual pay is set by the research site.

University of FloridaNCT07025148

OPN Balloon for SAFE Recanalization of Calcified Coronary Lesions (OPEN-SAFE Registry)

The goal of the OPEN-SAFE registry is to describe the contemporary use and outcomes of SIS-OPN in North America.

Coronary Arterial Disease (CAD)In Stent RestenosisCalcified Coronary Lesions

Estimated

~$10 – $750

Actual pay is set by the research site.

Minneapolis Heart Institute FoundationNCT07646444

Phase 4

The Bridging Antiplatelet Therapy With Cangrelor 2 (BRIDGE 2) Study: A Pilot Prospective Cohort, Pharmacodynamic Study of Tailored Cangrelor Bridging Dosing Regimens

The primary aim of this study is to determine rates of patients with optimal platelet reactivity range, defined as PRU levels between 85 and 208, when using a …

Coronary Arterial Disease (CAD)

Estimated

~$25 – $1,000

Actual pay is set by the research site.

University of FloridaNCT07225842

Phase 2

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Orticumab in Participants With Prior Myocardial Infarction Who Have Elevated Coronary Inflammation Based on FAI Score Assessed by CCTA

The goal of this clinical trial is to determine the clinical effect of orticumab treatment on inflammation in study participants with prior myocardial infarcti…

Acute Coronary SyndromesCoronary Arterial Disease (CAD)Inflammation+3 more

Estimated

~$75 – $3,000

Actual pay is set by the research site.

AbcentraNCT06927739

Observational

Prospective, Multicenter, Single-Arm, Investigational Device Exemption (IDE) Study of the Shockwave Intravascular Lithotripsy (IVL) System With the Shockwave Javelin Coronary IVL Catheter (FORWARD CAD IDE Study)

The FORWARD CAD IDE Study is a Prospective, Multicenter, Single-Arm, Investigational Device Exemption (IDE) Study conducted to assess the safety and effectiven…

Coronary Arterial Disease (CAD)

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Shockwave Medical, Inc.NCT06662500